Arcus Biosciences, Inc. (RCUS) key performance indicators and operating metrics (2 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| License and Development Services Revenue | 20M | FY2025-Q3 |
| Other Collaboration Revenue | 6M | FY2025-Q3 |
Back to RCUS overview · RCUS earnings · RCUS holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.